|
1.
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics. CA Cancer J Clin. 60:277–300. 2010.
|
|
2.
|
Toyooka S, Mitsudomi T, Soh J, et al:
Molecular oncology of lung cancer. Gen Thorac Cardiovasc Surg.
59:527–537. 2011.
|
|
3.
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
|
|
4.
|
Ambros V: MicroRNA pathways in flies and
worms: growth, death, fat, stress, and timing. Cell. 113:673–676.
2003.
|
|
5.
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005.
|
|
6.
|
Otaegi G, Pollock A, Hong J and Sun T:
MicroRNA miR-9 modifies motor neuron columns by a tuning regulation
of FoxP1 levels in developing spinal cords. J Neurosci. 31:809–818.
2011.
|
|
7.
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in Cancer. Annu Rev Med. 60:167–179. 2009.
|
|
8.
|
Ma L, Young J, Prabhala H, et al: miR-9, a
MYC/MYCN-activated microRNA, regulates E-cadherin and cancer
metastasis. Nat Cell Biol. 12:247–256. 2010.
|
|
9.
|
Korpal M, Ell BJ, Buffa FM, et al: Direct
targeting of Sec23a by miR-200s influences cancer cell secretome
and promotes metastatic colonization. Nat Med. 17:1101–1108.
2011.
|
|
10.
|
Myatt SS, Wang J, Monteiro LJ, et al:
Definition of microRNAs that repress expression of the tumor
suppressor gene FOXO1 in endometrial cancer. Cancer Res.
70:367–377. 2010.
|
|
11.
|
Saito Y, Liang G, Egger G, et al: Specific
activation of microRNA-127 with downregulation of the
proto-oncogene BCL6 by chromatin-modifying drugs in human cancer
cells. Cancer Cell. 9:435–443. 2006.
|
|
12.
|
Lehmann U, Hasemeier B, Christgen M, et
al: Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human
breast cancer. J Pathol. 214:17–24. 2008.
|
|
13.
|
Hildebrandt MA, Gu J, Lin J, et al: Hsa-
miR-9s methylation status is associated with cancer development and
metastatic recurrence in patients with clear cell renal cell
carcinoma. Oncogene. 29:5724–5728. 2010.
|
|
14.
|
Lujambio A, Calin GA, Villanueva A, et al:
A microRNA DNA methylation signature for human cancer metastasis.
Proc Natl Acad Sci USA. 105:13556–13561. 2008.
|
|
15.
|
Xiong Z and Laird PW: COBRA: a sensitive
and quantitative DNA methylation assay. Nucleic Acids Res.
25:2532–2534. 1997.
|
|
16.
|
Herrmann BG and Frischauf AM: Isolation of
genomic DNA. Methods Enzymol. 152:180–183. 1987.
|
|
17.
|
Venneti S, Boateng LA, Friedman JR, et al:
MiR-9 and MiRNA-200a distinguish hemangioblastomas from metastatic
clear cell renal cell carcinomas in the CNS. Brain Pathol.
22:522–529. 2012.
|
|
18.
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006.
|
|
19.
|
Takamizawa J, Konishi H, Yanagisawa K, et
al: Reduced expression of the let-7 microRNAs in human lung cancers
in association with shortened postoperative survival. Cancer Res.
64:3753–3756. 2004.
|
|
20.
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006.
|
|
21.
|
Toyooka S, Toyooka KO, Miyajima K, et al:
Epigenetic down-regulation of death-associated protein kinase in
lung cancers. Clin Cancer Res. 9:3034–3041. 2003.
|
|
22.
|
Lujambio A, Ropero S, Ballestar E, et al:
Genetic unmasking of an epigenetically silenced microRNA in human
cancer cells. Cancer Res. 67:1424–1429. 2007.
|
|
23.
|
Toyota M, Suzuki H, Sasaki Y, et al:
Epigenetic silencing of microRNA-34b/c and B-cell translocation
gene 4 is associated with CpG island methylation in colorectal
cancer. Cancer Res. 68:4123–4132. 2008.
|
|
24.
|
Devereux TR, Horikawa I, Anna CH, Annab
LA, Afshari CA and Barrett JC: DNA methylation analysis of the
promoter region of the human telomerase reverse transcriptase
(hTERT) gene. Cancer Res. 59:6087–6090. 1999.
|
|
25.
|
Santini V, Kantarjian HM and Issa JP:
Changes in DNA methylation in neoplasia: pathophysiology and
therapeutic implications. Ann Intern Med. 134:573–586. 2001.
|
|
26.
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.
|
|
27.
|
Scartozzi M, Bearzi I, Mandolesi A, et al:
Epidermal growth factor receptor (EGFR) gene promoter methylation
and cetuximab treatment in colorectal cancer patients. Br J Cancer.
104:1786–1790. 2011.
|
|
28.
|
Khew-Goodall Y and Goodall GJ:
Myc-modulated miR-9 makes more metastases. Nat Cell Biol.
12:209–211. 2010.
|
|
29.
|
Tsai KW, Liao YL, Wu CW, et al: Aberrant
hypermethylation of miR-9 genes in gastric cancer. Epigenetics.
6:1189–1197. 2011.
|
|
30.
|
Gravgaard KH, Lyng MB, Laenkholm AV, et
al: The miRNA-200 family and miRNA-9 exhibit differential
expression in primary versus corresponding metastatic tissue in
breast cancer. Breast Cancer Res Treat. 2012.
|
|
31.
|
Heller G, Weinzierl M, Noll C, et al:
Genome-wide miRNA expression profiling identifies miR-9-3 and
miR-193a as targets for DNA methylation in non-small cell lung
cancers. Clin Cancer Res. 18:1619–1629. 2012.
|
